[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wilson et al., 2014 - Google Patents

Synthetic methods for the preparation of platinum anticancer complexes

Wilson et al., 2014

View HTML
Document ID
1744417832541915836
Author
Wilson J
Lippard S
Publication year
Publication venue
Chemical reviews

External Links

Snippet

The demonstration in the 1960s that cis-diamminedichloroplatinum (II), or cisplatin, inhibits cellular division of Escherichia coli 1 led to the subsequent discovery that this simple coordination compound is also an effective antitumor agent in mouse models. 2 Subsequent …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0073Rhodium compounds
    • C07F15/008Rhodium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/002Osmium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0033Iridium compounds
    • C07F15/004Iridium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/06Cobalt compounds
    • C07F15/065Cobalt compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/04Nickel compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System

Similar Documents

Publication Publication Date Title
Wilson et al. Synthetic methods for the preparation of platinum anticancer complexes
Haribabu et al. Water-soluble mono-and binuclear Ru (η6-p-cymene) complexes containing indole thiosemicarbazones: synthesis, DFT modeling, biomolecular interactions, and in vitro anticancer activity through apoptosis
Galanski Recent developments in the field of anticancer platinum complexes
Marques Platinum and palladium polyamine complexes as anticancer agents: the structural factor
Komeda et al. New isomeric azine-bridged dinuclear platinum (II) complexes circumvent cross-resistance to cisplatin
Talman et al. Crystal and molecular structures of asymmetric cis-and trans-platinum (II/IV) compounds and their reactions with DNA fragments
Kalinowska-Lis et al. Trans geometry in platinum antitumor complexes
Galanski et al. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches
Varbanov et al. A novel class of bis-and tris-chelate diam (m) inebis (dicarboxylato) platinum (IV) complexes as potential anticancer prodrugs
Krause-Heuer et al. Studies of the mechanism of action of platinum (II) complexes with potent cytotoxicity in human cancer cells
Koumousi et al. First palladium (II) and platinum (II) complexes from employment of 2, 6-diacetylpyridine dioxime: synthesis, structural and spectroscopic characterization, and biological evaluation
Cui et al. Bispidine analogues of cisplatin, carboplatin, and oxaliplatin. synthesis, structures, and cytotoxicity
Hotze et al. Synthesis, characterization, and crystal structure of α-[Ru (azpy) 2 (NO3) 2](azpy= 2-(Phenylazo) pyridine) and the products of its reactions with guanine derivatives
Rauterkus et al. Cisplatin analogues with 2, 2′-dipyridylamine ligands and their reactions with DNA model nucleobases
Gukathasan et al. Cyclometalated Gold (III) complexes bearing DACH ligands
Hochreuther et al. Thermodynamic and kinetic studies on novel dinuclear platinum (II) complexes containing bidentate N, N-donor ligands
Wang Fresh platinum complexes with promising antitumor activity
Scaffidi-Domianello et al. Synthesis, characterization, and cytotoxic activity of novel potentially pH-sensitive nonclassical platinum (II) complexes featuring 1, 3-dihydroxyacetone oxime ligands
Messori et al. Reactivity and biological properties of a series of cytotoxic PtI2 (amine) 2 complexes, either cis or trans configured
Makarycheva-Mikhailova et al. Platinum (IV)-mediated nitrile− sulfimide coupling: a route to heterodiazadienes
Pichler et al. Bulky N (, N)-(di) alkylethane-1, 2-diamineplatinum (II) compounds as precursors for generating unsymmetrically substituted platinum (IV) complexes
Bokach et al. Direct addition of alcohols to organonitriles activated by ligation to a platinum (IV) center
US8324197B2 (en) Transplatinum complexes with N2O2 donor sets as cytotoxic and antitumor agents
Graziani et al. Activation and reactivity of a bispidine analogue of cisplatin: A theoretical investigation
Summa et al. The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt II (1, 2-trans-R, R-diaminocyclohexane)(X–Y) complexes